| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.63B | 67.30B | 69.22B | 58.57B | 56.87B | 51.53B |
| Gross Profit | 23.10B | 22.31B | 22.57B | 19.49B | 19.14B | 16.21B |
| EBITDA | 18.05B | 17.87B | 17.85B | 15.18B | 15.40B | 12.69B |
| Net Income | 9.14B | 9.31B | 9.46B | 8.67B | 8.38B | 6.52B |
Balance Sheet | ||||||
| Total Assets | 114.24B | 113.64B | 108.64B | 100.26B | 99.40B | 95.83B |
| Cash, Cash Equivalents and Short-Term Investments | 29.66B | 30.92B | 29.16B | 27.85B | 34.45B | 34.26B |
| Total Debt | 5.68B | 6.40B | 5.29B | 3.54B | 3.35B | 4.31B |
| Total Liabilities | 20.04B | 19.78B | 19.20B | 15.83B | 15.96B | 15.11B |
| Stockholders Equity | 84.26B | 84.33B | 80.61B | 76.50B | 75.95B | 73.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.58B | 7.64B | 3.79B | 8.36B | 7.13B |
| Operating Cash Flow | 0.00 | 13.82B | 13.79B | 9.92B | 11.70B | 9.78B |
| Investing Cash Flow | 0.00 | -7.28B | -8.25B | -8.30B | -3.83B | 981.00M |
| Financing Cash Flow | 0.00 | -5.32B | -4.14B | -8.03B | -7.62B | -3.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥185.99B | 17.31 | 11.00% | 2.20% | 6.63% | -3.05% | |
73 Outperform | ¥27.84B | 7.02 | ― | 2.62% | -9.37% | 590.66% | |
73 Outperform | ¥396.08B | 25.33 | ― | 1.30% | 8.33% | 1.73% | |
66 Neutral | ¥7.46B | 16.59 | ― | 1.36% | 3.68% | -24.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥5.18B | 7.76 | ― | 1.80% | -0.27% | 0.09% | |
56 Neutral | ¥2.21B | 104.52 | ― | 1.93% | -1.19% | -89.91% |